TrialInternational journal of impotence research2019

Patient perspectives on Peyronie's disease: results of poststudy interviews from a phase 2 trial of collagenase clostridium histolyticum.

J Kaminetsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.